FDA official logo
GSRS logo
PFDA official logo

ADALIMUMAB

  • UNII: FYS6T7F842
  • Preferred Substance Name: ADALIMUMAB

  • 331731-18-1
  • ABP-501
  • ABRILADA
  • ADALIMUMAB (ABBVIE)
  • ADALIMUMAB (GENETICAL RECOMBINATION)
  • ADALIMUMAB (GENETICAL RECOMBINATION) [JAN]
  • ADALIMUMAB (HUMIRA)
  • ADALIMUMAB [EMA EPAR]
  • ADALIMUMAB [HSDB]
  • ADALIMUMAB [INN]
  • ADALIMUMAB [JAN]
  • ADALIMUMAB [MART.]
  • ADALIMUMAB [MI]
  • ADALIMUMAB [PURPLE BOOK CDER]
  • ADALIMUMAB [USAN]
  • ADALIMUMAB [VANDF]
  • ADALIMUMAB [WHO-DD]
  • ADALIMUMAB ADAZ [WHO-DD]
  • ADALIMUMAB ADBM [WHO-DD]
  • ADALIMUMAB AFZB [WHO-DD]
  • ADALIMUMAB AQVH [WHO-DD]
  • ADALIMUMAB ATTO [WHO-DD]
  • ADALIMUMAB BETA
  • ADALIMUMAB BETA [INN]
  • ADALIMUMAB BIOSIMILAR (ALVOTECH)
  • ADALIMUMAB BIOSIMILAR (AMGEN)
  • ADALIMUMAB BIOSIMILAR (AVT02)
  • ADALIMUMAB BIOSIMILAR (BOEHRINGER INGELHEIM)
  • ADALIMUMAB BIOSIMILAR (CELLTRION)
  • ADALIMUMAB BIOSIMILAR (COHERUS BIOSCIENCES)
  • ADALIMUMAB BIOSIMILAR (CT-P17)
  • ADALIMUMAB BIOSIMILAR (FKB-327)
  • ADALIMUMAB BIOSIMILAR (FUJIFILM KYOWA KIRIN BIOLOGICS)
  • ADALIMUMAB BIOSIMILAR (MSB11022)
  • ADALIMUMAB BIOSIMILAR (MYLAN)
  • ADALIMUMAB BIOSIMILAR (PF-06410293)
  • ADALIMUMAB BIOSIMILAR (PFIZER)
  • ADALIMUMAB BIOSIMILAR (SAMSUNG BIOEPIS)
  • ADALIMUMAB BIOSIMILAR (SANDOZ)
  • ADALIMUMAB BIOSIMILAR (YUSIMRY)
  • ADALIMUMAB BIOSIMILAR (ZRC-3197)
  • ADALIMUMAB BWWD [WHO-DD]
  • ADALIMUMAB FKJP [WHO-DD]
  • ADALIMUMAB, LICENSE HOLDER UNSPECIFIED
  • ADALIMUMAB-AACF
  • ADALIMUMAB-AATY
  • ADALIMUMAB-ADAZ
  • ADALIMUMAB-ADAZ [PURPLE BOOK CDER]
  • ADALIMUMAB-ADBM
  • ADALIMUMAB-ADBM [PURPLE BOOK CDER]
  • ADALIMUMAB-AFZB
  • ADALIMUMAB-AQVH
  • ADALIMUMAB-ATTO
  • ADALIMUMAB-ATTO [PURPLE BOOK CDER]
  • ADALIMUMAB-BWWD
  • ADALIMUMAB-FKJP
  • AMJEVITA
  • AMSPARITY
  • AVT02
  • AVT-02
  • BCD-057
  • BI 695501 [WHO-DD]
  • BI695501
  • BI-695501
  • CHS-1420
  • CTP17
  • CT-P17
  • CYLTEZO
  • D2E7
  • D3E7
  • EXEMPTIA
  • FKB-327
  • GP2017
  • GP-2017
  • HADLIMA
  • HULIO
  • HUMIRA
  • HYRIMOZ
  • IDACIO
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER
  • LBAL
  • LU200134
  • LU-200134
  • M923
  • M-923
  • MSB11022
  • MSB-11022
  • ONS-3010
  • PF-06410293
  • SB5
  • SB-5
  • TRUDEXA
  • YUFLYMA
  • YUSIMRY
  • ZRC3197
  • ZRC-3197

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.




About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

Powered by

DNAnexus official logo